Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Peter D Cole

Markers of Cognitive Decline During Treatment for Childhood ALL

Leukaemia

Theodore S Jardetzky

Inhibitors of the Epstein-Barr Virus Entry Machinery

Hodgkin lymphoma Non-Hodgkin lymphoma

Corey Casper

Uganda Cancer Institute / Hutchinson Center Cancer Alliance (UCI/HCCA)

Hodgkin lymphoma Non-Hodgkin lymphoma Breast

Ellen P Mccarthy

Integrating Competing Risks into the CISNET DFCI Breast Cancer Model

Breast

Melinda Sue Butschkovacic

Fanconi Anemia as a Model for Susceptibility to Human Papillomavirus Infection

Hodgkin lymphoma Non-Hodgkin lymphoma

Peng Huang

ROS, Redox Regulation and Novel Targets for Cancer Therapy

Leukaemia

Vikas Kundra

Personalizing Nanoparticle Therapy

Breast

Peter Kingham

African Research Group for Oncology Breast Cancer Studies in Nigeria

Breast